Use of the Cumulative Proportion of Responders Analysis Graph to Present Pain Data Over a Range of Cut-Off Points: Making Clinical Trial Data More Understandable

Slides:

Advertisements

Similar presentations

Treatment of postherpetic neuralgia: a review of therapeutic options Charles E. Argoff, MD, Nathaniel Katz, MD, Miroslav Backonja, MD Journal of Pain and.

Advertisements

Validation of the Wisconsin Brief Pain Questionnaire in a Multilingual South African Population Noko Mphahlele, MSc, Duncan Mitchell, PhD, Peter Kamerman,

Spinal Cord and Peripheral Nerve Stimulation Techniques for Neuropathic Pain Oscar A. de Leon-Casasola, MD Journal of Pain and Symptom Management Volume.

Comparison of the Constipation Assessment Scale and Plain Abdominal Radiography in the Assessment of Constipation in Advanced Cancer Patients Kittiphon.

Management of Phantom Pain with a Textile, Electromagnetically-Acting Stump Liner: A Randomized, Double-Blind, Crossover Study Uwe Kern, MD, Bernd Altkemper,

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Shuangbai San for Treating Primary Liver Cancer Patients With Cancer Pain Xiaowei.

Chronic Pain Management in Older Adults: Special Considerations

Transcutaneous Electrical Nerve Stimulation vs

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Patient-Reported Outcomes as a Component of the Primary Endpoint in a Double-Blind, Placebo-Controlled Trial in Advanced Pancreatic Cancer S. Gail Eckhardt,

Characterization of Abdominal Pain During Methylnaltrexone Treatment of Opioid- Induced Constipation in Advanced Illness: A Post Hoc Analysis of Two Clinical.

Is Oxycodone Efficacy Reflected in Serum Concentrations

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Transcutaneous Electrical Nerve Stimulation vs

Chronic Pain Management in Older Adults: Special Considerations

Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain Relief Giovambattista Zeppetella, FRCP Journal.

Edmonton, Canada: A Regional Model of Palliative Care Development

Pain Severity in Diabetic Peripheral Neuropathy is Associated with Patient Functioning, Symptom Levels of Anxiety and Depression, and Sleep Mugdha Gore,

A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced.

David M. Simpson, MD, Lydia Estanislao, MD, Stephen J

What Influences Patients’ Decisions on Artificial Hydration at the End of Life? A Q- Methodology Study Catherine Malia, MSc, Michael I. Bennett, MB, ChB,

Once-Daily Gastroretentive Gabapentin for Postherpetic Neuralgia: Integrated Efficacy, Time to Onset of Pain Relief and Safety Analyses of Data From Two.

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

The Effect of a Multimodal Intervention on Treatment-Related Symptoms in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Controlled.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Shuangbai San for Treating Primary Liver Cancer Patients With Cancer Pain Xiaowei.

Double-Blind, Placebo-Controlled Trial of Lamotrigine in Combination with Other Medications for Neuropathic Pain Marianne Silver, MS, David Blum, MD,

Bruce H. Chamberlain, MD, Karen Cross, MD, Jaron L

A randomized, double-blind, crossover study of the use of transcutaneous spinal electroanalgesia in patients with pain from chronic critical limb ischemia

Gastrointestinal Effects of NSAIDs and Coxibs

Tetrodotoxin for Moderate to Severe Cancer Pain: A Randomized, Double Blind, Parallel Design Multicenter Study Neil A. Hagen, MD, FRCPC, Patrick du Souich,

David Clark, PhD, Michael Wright, PhD

Redefining Appropriate Treatment Expectations

Treatment of Cancer Pain with Noninvasive Brain Stimulation

Transcutaneous Electrical Nerve Stimulation vs

Characterization of the early pharmacodynamic profile of oral methadone for cancer- related breakthrough pain: a pilot study Kim Fisher, PhD, Carla Stiles,

L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study Ricardo A. Cruciani,

Jodi L. Hannan, MD, Steven M. Radwany, MD, Terry Albanese, PhD

Evaluation of Methadone Absorption After Topical Administration to Hospice Patients Robert K. Sylvester, PharmD, Caroline Schauer, RN, John Thomas, MD,

A Pilot Randomized Controlled Trial of an Oral Care Intervention to Reduce Mucositis Severity in Stem Cell Transplant Patients Prisco Salvador, RN, MScN,

Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms Anna-Liisa Kautio, MD, Maija Haanpää, MD, PhD, Tiina Saarto, MD, PhD, Eija.

Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD

A Proposed Taxonomy of Terms to Guide the Clinical Trial Recruitment Process Neil A. Hagen, MD, FRCPC, Jackson S. Wu, MD, FRCPC, Carla R. Stiles, BN

Robert L. Jayes, MD, Robert M. Arnold, MD, Erik K. Fromme, MD

Susan C. Miller, PhD, Dan K. Kiely, MPH, MA, Joan M

Do Interference-Based Cut-Points Differentiate Mild, Moderate, and Severe Levels of 16 Cancer-Related Symptoms Over Time? Sangchoon Jeon, MS, Charles.

Use of Personalized Decision Analysis in Decision Making for Palliative vs. Surgical Management of the Oldest-Old Patients With Localized Skin Cancer.

Effects of Methylphenidate on Fatigue and Depression: A Randomized, Double-Blind, Placebo-Controlled Trial Christopher W. Kerr, MD, PhD, Julie Drake,

U.S. Hospice Benefits Journal of Pain and Symptom Management

Armodafinil for Sarcoidosis-Associated Fatigue: A Double-Blind, Placebo-Controlled, Crossover Trial Elyse E. Lower, MD, Atul Malhotra, MD, Victoria Surdulescu,

Calibration of Quality-Adjusted Life Years for Oncology Clinical Trials Jeff A. Sloan, PhD, Daniel J. Sargent, PhD, Paul J. Novotny, MS, Paul A. Decker,

Randomized, Double-Blind, Placebo-Controlled Trial of Oral Docusate in the Management of Constipation in Hospice Patients Yoko Tarumi, MD, Mitchell P.

A Spicamycin Derivative (KRN5500) Provides Neuropathic Pain Relief in Patients With Advanced Cancer: A Placebo-Controlled, Proof-of-Concept Trial Sharon.

Charlene L. Taylor, RN, BSN Journal of Pain and Symptom Management

Development and Reliability Testing of the Victoria Bowel Performance Scale (BPS) G. Michael Downing, MD, Craig Kuziemsky, PhD, Mary Lesperance, PhD,

Association Between Symptom Distress and Survival in Outpatients Seen in a Palliative Care Cancer Center J. Lynn Palmer, PhD, Michael J. Fisch, MD, MPH

Comparative Efficacy of Oral Extended-Release Hydromorphone and Immediate- Release Hydromorphone in Patients with Persistent Moderate to Severe Pain: Two.

A Double-Blind, Randomized, Crossover Comparison Between Single-Dose and Double-Dose Immediate-Release Oral Morphine at Bedtime in Cancer Patients Ola.

Gabapentin and an Opioid Combination Versus Opioid Alone for the Management of Neuropathic Cancer Pain: A Randomized Open Trial Kader Keskinbora, MD,

Clinical and Economic Impact of Palliative Care Consultation

Efficacy and Safety of Transdermal Buprenorphine: A Randomized, Placebo-Controlled Trial in 289 Patients with Severe Cancer Pain Philippe Poulain, MD,

Effects of Prophylactic Subcutaneous Fentanyl on Exercise-Induced Breakthrough Dyspnea in Cancer Patients: A Preliminary Double-Blind, Randomized, Controlled.

Management of Phantom Pain with a Textile, Electromagnetically-Acting Stump Liner: A Randomized, Double-Blind, Crossover Study Uwe Kern, MD, Bernd Altkemper,

Amy P. Abernethy, MD Journal of Pain and Symptom Management

Helping Patients with Advanced Cancer Live with Concerns About Eating: A Challenge for Palliative Care Professionals Jane Hopkinson, PhD, RGN, Jessica.

Advance Directives in Japanese Nursing Homes

Cancer Symptom Clusters: A Validation Study

Associations Between Physical Activity and Quality of Life in Cancer Patients Receiving Palliative Care: A Pilot Survey Sonya S. Lowe, MD, MSc, Sharon.

Use of Pregabalin in the Management of Chronic Uremic Pruritus

Randomized Double-Blind Trial of Sublingual Atropine vs

Presentation transcript:

Use of the Cumulative Proportion of Responders Analysis Graph to Present Pain Data Over a Range of Cut-Off Points: Making Clinical Trial Data More Understandable John T. Farrar, MD, PhD, Robert H. Dworkin, PhD, Mitchell B. Max, MD Journal of Pain and Symptom Management Volume 31, Issue 4, Pages 369-377 (April 2006) DOI: 10.1016/j.jpainsymman.2005.08.018 Copyright © 2006 U.S. Cancer Pain Relief Committee Terms and Conditions

Fig. 1 A CPRA graph created with percent change in 0–10 NRS pain intensity data from a randomized, double-blind clinical trial of patients with cancer-related breakthrough pain treated with OTFC vs. placebo. Journal of Pain and Symptom Management 2006 31, 369-377DOI: (10.1016/j.jpainsymman.2005.08.018) Copyright © 2006 U.S. Cancer Pain Relief Committee Terms and Conditions

Fig. 2 A CPRA graph created with percent change in 0–10 NRS pain intensity data from a randomized, double-blind clinical trial of patients with cancer-related breakthrough pain treated with OTFC vs. MSIR. Journal of Pain and Symptom Management 2006 31, 369-377DOI: (10.1016/j.jpainsymman.2005.08.018) Copyright © 2006 U.S. Cancer Pain Relief Committee Terms and Conditions

Fig. 3 A CPRA graph created with percent change in 0–10 NRS pain intensity data from a randomized, double-blind clinical trial of patients with postherpetic neuralgia treated with an oral dose of 600mg/day of pregabalin vs. placebo (300mg/day was administered to patients with creatinine clearances of less than 30 to achieve a similar concentration of pregabalin as the 600mg group). Journal of Pain and Symptom Management 2006 31, 369-377DOI: (10.1016/j.jpainsymman.2005.08.018) Copyright © 2006 U.S. Cancer Pain Relief Committee Terms and Conditions

Fig. 4 A CPRA graph created with Gracely scale pain intensity difference data between week 1 and week 6 from a randomized, double-blind clinical trial of patients with diabetic neuropathic pain treated with amitriptyline, desipramine, fluoxetine, or placebo. Journal of Pain and Symptom Management 2006 31, 369-377DOI: (10.1016/j.jpainsymman.2005.08.018) Copyright © 2006 U.S. Cancer Pain Relief Committee Terms and Conditions

Fig. 5 A CPRA graph created with the global change score between week 1 and week 6 for all groups from a randomized, double-blind clinical trial of patients with diabetic neuropathic pain treated with amitriptyline, desipramine, fluoxetine, or placebo. Journal of Pain and Symptom Management 2006 31, 369-377DOI: (10.1016/j.jpainsymman.2005.08.018) Copyright © 2006 U.S. Cancer Pain Relief Committee Terms and Conditions